Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 9786523Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2025
Linked Award Amount
$3.8M
Full award amounts, FY2025
Award Records
5
Records listing this PI
Award-Linked Rank
#2,293
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $3.8M in linked award amounts across 5 award records · Award-linked rank #2293.
FY2025 award records by amount
NIH award records listing Laurie Tate Krug as a PI. Multi-PI records show the full award amount for context.
- 1ZIABC011953-06ZIAInvestigation of viral and host determinants of gammaherpesvirus pathogenesis$1.1Maward amount
- 1ZIABC012014-06ZIANovel interventions for gammaherpesvirus infection and AIDS-Related Malignancies$1.1Maward amount
- 1ZIABC012173-02ZIAStrategic Herpesvirus Immune Evasion and Latency Defense$841.3Kaward amount
- 1ZIABC012200-01ZIAViral and Genetic Drivers of Growth and Metastasis of Anaplastic Kaposi Sarcoma in People Living with HIV$636.9Kaward amount
- 1ZIABC012201-01ZIASingle-cell Analysis of Primary Effusion Lymphoma Patient-Derived Xenografts from HIV-AIDS Patients to Identify Molecular Targets for Intervention$113.7Kaward amount
Award organization
Organizations that administered FY2025 awards listing Laurie Tate Krug as a PI.
FY2025 award administered by Division of Basic Sciences - Nci ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardDivision of Basic Sciences - Nci
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #2293
- 2025Entered Top 25% NationallyRanked #2293